Fuster, Daniel <br/><br/>
Short communication. Baseline factors associated with haematological toxicity that leads to a dosage reduction of pegylated interferon-alpha2a and ribavirin in HIV- and HCV-coinfected patients on HCV antiviral therapy.  [electronic resource] 

 -  Antiviral therapy  2005 
 - 841-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1359-6535 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--administration & dosage<br/>Female<br/>HIV Infections--complications<br/>Hepatitis C--complications<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--administration & dosage<br/>Male<br/>Middle Aged<br/>Polyethylene Glycols--administration & dosage<br/>Prospective Studies<br/>Recombinant Proteins<br/>Ribavirin--administration & dosage<br/>Risk Factors